Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Journal of Hepatology|June 9, 2009
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinomaHitoshi Yoshiji, Ryuichi Noguchi, Masahisa Toyohara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 24, 2006
A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in ratsTadashi Namisaki, Hitoshi Yoshiji, Shigeki Kuriyama, et al.
Parasitology International|March 27, 2007
Cystic echinococcosis in immigrant from Peru: first case treated with percutaneous treatment in JapanHiroshi Sakaguchi, Toshihiro Tanaka, Nagaaki Marugami, et al.
Oncology Reports|May 28, 2013
Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistanceHitoshi Yoshiji, Ryuichi Noguchi, Tadashi Namisaki, et al.
World Journal of Gastroenterology|June 26, 2007
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosisHitoshi Yoshiji, Ryuichi Noguchi, Masaharu Yamazaki, et al.
Oncology Letters|August 8, 2012
Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agentsHitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, et al.
World Journal of Gastroenterology|July 31, 2007
Eosinophilic cholecystitis along with pericarditis caused by Ascaris lumbricoides: a case reportKosuke Kaji, Hitoshi Yoshiji, Masahide Yoshikawa, et al.
United European Gastroenterology Journal|November 3, 2018
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and CHiroaki Takaya, Hideto Kawaratani, Yuki Tsuji, et al.
World Journal of Gastroenterology|November 6, 2009
Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitisMitsuteru Kitade, Hitoshi Yoshiji, Ryuichi Noguchi, et al.
World Journal of Gastrointestinal Oncology|May 31, 2012
A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinomaYosuke Aihara, Hitoshi Yoshiji, Masaharu Yamazaki, et al.
Pageof 22